Finding 617882 (2022-003)

Material Weakness
Requirement
ABH
Questioned Costs
-
Year
2022
Accepted
2023-08-25
Audit: 37685
Auditor: Eide Bailly LLP

AI Summary

  • Core Issue: The Facility's expense tracking had errors, including future period expenses and returned items, leading to inaccuracies in reported costs.
  • Impacted Requirements: Compliance with 2 CFR 200.303(a) was compromised due to lack of effective internal controls and documentation over expense approvals.
  • Recommended Follow-Up: Implement a formal review and approval process for the expense tracking spreadsheet and ensure documentation is retained.

Finding Text

2022-003 Department of Health and Human Services Federal Financial Assistance Listing #93.697 COVID-19 Testing and Mitigation for Rural Health Clinics Activities Allowed or Unallowed and Allowable Costs/Cost Principles and Period of Performance Material Weakness in Internal Control over Compliance Criteria: 2 CFR 200.303(a) establishes that the auditee must establish and maintain effective internal control over federal awards that provides reasonable assurance that the Facility is managing the federal award in compliance with federal statutes, regulations and terms and conditions of the federal award. Condition: The Facility?s expense tracking spreadsheet which identified the expenses claimed under the federal program as allowable costs included three expenses which related to a future period. The Facility also claimed the cost of eleven chairs which had been returned to the third-party vendor during November 2022. A formula error was also identified within the calculation of clinic salaries and fringe benefits claimed under the federal program which was based upon a prorated basis of COVID related clinic visits as a percentage of total clinic visits. The Facility had multiple individuals identifying and compiling eligible expenses; however, the Facility?s review and approval process over the Facility?s expense tracking spreadsheet was not formally documented. Cause: The Facility?s review and approval process over the Facility?s expense tracking spreadsheet did not identify the future period expenses, the cost of the returned chairs, or the formula error. Effect: The Facility?s expense tracking spreadsheet which identified the expenses claimed under the federal program as allowable costs had more expenses identified than funds received; therefore, the expenses relating to a future period and the cost of the eleven chairs had no effect on the amount of federal expenditures included in the schedule of expenditures of federal awards for the year ending December 31, 2022 as excess expenses had been identified by the Facility on their expense tracking spreadsheet. Additional clinic salaries and fringe benefits could have been claimed under the federal program due to the formula error identified. Additionally, it is hard to determine if a review and approval process occurred as no documentation was retained to support the process. Questioned Costs: No questioned costs to report as the Facility?s expense tracking spreadsheet which identified the expenses claimed under the federal program as allowable costs included excess expenses over the amount of funds received. Context: Summary level testing was performed over clinic salaries and fringe benefits claimed under the federal program. In addition, a nonstatistical sample of 24 ($110,187) from a population of 127 nonpayroll items ($142,733) were tested. Repeat Finding from Prior Years: No Recommendation: We recommend the Facility implement a control process which includes an independent review and approval of the expense tracking spreadsheet which identifies the expenses claimed under the federal program as allowable costs and retain documentation of the review process. Views of Responsible Officials: Management agrees with the finding.

Categories

Allowable Costs / Cost Principles Material Weakness Period of Performance Reporting

Other Findings in this Audit

  • 41440 2022-003
    Material Weakness
  • 41441 2022-004
    Significant Deficiency
  • 41442 2022-005
    Material Weakness
  • 617883 2022-004
    Significant Deficiency
  • 617884 2022-005
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
93.498 Provider Relief Fund $328,978
93.697 Covid-19 Testing for Rural Health Clinics $300,000
93.155 Rural Health Research Centers $258,376
10.766 Community Facilities Loans and Grants $139,816
93.461 Covid-19 Testing for the Uninsured $23,977
93.301 Small Rural Hospital Improvement Grant Program $12,836
10.557 Special Supplemental Nutrition Program for Women, Infants, and Children $4,934